Education
About Us
Working with TipRanks
Follow Us
Ventyx Biosciences (VTYX)
NASDAQ:VTYX
Total Valuation
Ventyx Biosciences has a market cap or net worth of $585.85M. The enterprise value is $39.14M.
Market Cap$585.85M
Enterprise Value$39.14M
Share Statistics
Ventyx Biosciences has 71,358,635 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding71,358,635
Owned by Insiders9.73%
Owned by Institutions24.16%
Financial Efficiency
Ventyx Biosciences’s return on equity (ROE) is -0.53 and return on invested capital (ROIC) is -56.05%.
Return on Equity (ROE)-0.53
Return on Assets (ROA)-0.49
Return on Invested Capital (ROIC)-56.05%
Return on Capital Employed (ROCE)-0.56
Revenue Per Employee0.00
Profits Per Employee-1.67M
Employee Count81
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Ventyx Biosciences is ―. Ventyx Biosciences’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio0.59
Price to Fair Value0.59
Price to FCF-1.14
Price to Operating Cash Flow-7.64
PEG Ratio0.03
Income Statement
In the last 12 months, Ventyx Biosciences had revenue of 0.00 and earned -135.12M in profits. Earnings per share was -1.97.
Revenue0.00
Gross Profit0.00
Operating Income-148.45M
Pretax Income-135.12M
Net Income-135.12M
EBITDA-147.10M
Earnings Per Share (EPS)-1.97
Cash Flow
In the last 12 months, operating cash flow was -87.75M and capital expenditures -114.00K, giving a free cash flow of -87.87M billion.
Operating Cash Flow-87.75M
Free Cash Flow-87.87M
Free Cash Flow per Share-1.23
Dividends & Yields
Ventyx Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.39
52-Week Price Change237.28%
50-Day Moving Average7.59
200-Day Moving Average3.47
Relative Strength Index (RSI)42.02
Average Volume (3m)1.95M
Important Dates
Ventyx Biosciences upcoming earnings date is Mar 19, 2026, After Close (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateMar 19, 2026
Ex-Dividend Date―
Financial Position
Ventyx Biosciences as a current ratio of 17.97, with Debt / Equity ratio of 5.24%
Current Ratio17.97
Quick Ratio17.97
Debt to Market Cap0.00
Net Debt to EBITDA0.12
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Ventyx Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Ventyx Biosciences EV to EBITDA ratio is -1.00, with an EV/FCF ratio of -1.02.
EV to Sales0.00
EV to EBITDA-1.00
EV to Free Cash Flow-1.02
EV to Operating Cash Flow-1.02
Balance Sheet
Ventyx Biosciences has $192.64M in cash and marketable securities with $10.02M in debt, giving a net cash position of $182.61M billion.
Cash & Marketable Securities$192.64M
Total Debt$10.02M
Net Cash$182.61M
Net Cash Per Share$2.56
Tangible Book Value Per Share$3.71
Margins
Gross margin is 3.11%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin3.11%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Ventyx Biosciences is $13.71, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$13.71
Price Target Upside78.28% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast―
EPS Growth Forecast36.65%